PTGX Financial Statements

Balance sheet, income statement, cash flow, and dividends for Protagonist Therapeutics Inc (PTGX).


$2.30B Market Cap.

As of 02/24/2025 5:00 PM ET (MRY) • Disclaimer

PTGX Market Cap. (MRY)


PTGX Shares Outstanding (MRY)


PTGX Assets (MRY)


Total Assets

$744.73M

Total Liabilities

$69.43M

Total Investments

$461.92M

PTGX Income (MRY)


Revenue

$434.43M

Net Income

$275.19M

Operating Expense

$181.59M

PTGX Cash Flow (MRY)


CF Operations

$184.15M

CF Investing

-$299.48M

CF Financing

$25.85M

PTGX Dividends (MRY)


Period

Dividends

Yield %

Growth %

Payout Ratio

Coverage Ratio

2024

$0

0%

0%

0%

-

2023

$0

0%

0%

0%

-

2022

$0

0%

0%

0%

-

2021

$0

0%

0%

0%

-

2020

$0

0%

-

0%

-

PTGX Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$744,725,000 (108.05%)

$357,951,000 (44.38%)

$247,928,000 (-28.69%)

$347,695,000 (7.16%)

Assets Current

$591,641,000 (66.39%)

$355,577,000 (46.28%)

$243,077,000 (-28.66%)

$340,736,000 (7.96%)

Assets Non-Current

$153,084,000 (6348.36%)

$2,374,000 (-51.06%)

$4,851,000 (-30.29%)

$6,959,000 (-21.47%)

Goodwill & Intangible Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Shareholders Equity

$675,295,000 (100.58%)

$336,677,000 (56.15%)

$215,608,000 (-28.14%)

$300,021,000 (7.30%)

Property Plant & Equipment Net

$12,607,000 (486.64%)

$2,149,000 (-53.55%)

$4,626,000 (-31.30%)

$6,734,000 (5.02%)

Cash & Equivalents

$97,249,000 (-47.92%)

$186,727,000 (48.50%)

$125,744,000 (1.68%)

$123,665,000 (5.37%)

Accumulated Other Comprehensive Income

-$82,000 (21.90%)

-$105,000 (70.75%)

-$359,000 (-20.07%)

-$299,000 (-1167.86%)

Deferred Revenue

$30,567,000 (0%)

$0 (0%)

$0 (0%)

$1,601,000 (-88.94%)

Total Investments

$461,916,000 (198.22%)

$154,890,000 (38.78%)

$111,611,000 (-45.08%)

$203,235,000 (6.71%)

Investments Current

$321,664,000 (107.67%)

$154,890,000 (38.78%)

$111,611,000 (-45.08%)

$203,235,000 (7.85%)

Investments Non-Current

$140,252,000 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Inventory

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Receivables

$165,000,000 (1550.00%)

$10,000,000 (99900.00%)

$10,000 (-99.36%)

$1,566,000 (-35.45%)

Trade & Non-Trade Payables

$1,615,000 (108.39%)

$775,000 (-79.10%)

$3,709,000 (48.42%)

$2,499,000 (-56.97%)

Accumulated Retained Earnings (Deficit)

-$340,522,000 (44.69%)

-$615,710,000 (-14.71%)

-$536,755,000 (-31.12%)

-$409,362,000 (-44.24%)

Tax Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Tax Liabilities

$2,689,000 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Debt

$10,866,000 (852.32%)

$1,141,000 (-68.79%)

$3,656,000 (-37.59%)

$5,858,000 (-1.69%)

Debt Current

$510,000 (-55.30%)

$1,141,000 (-54.63%)

$2,515,000 (14.32%)

$2,200,000 (50.79%)

Debt Non-Current

$10,356,000 (0%)

$0 (0%)

$1,141,000 (-68.81%)

$3,658,000 (-18.71%)

Total Liabilities

$69,430,000 (226.36%)

$21,274,000 (-34.18%)

$32,320,000 (-32.21%)

$47,674,000 (6.27%)

Liabilities Current

$47,398,000 (122.80%)

$21,274,000 (-31.77%)

$31,179,000 (-29.16%)

$44,016,000 (9.38%)

Liabilities Non-Current

$22,032,000 (0%)

$0 (0%)

$1,141,000 (-68.81%)

$3,658,000 (-20.84%)

PTGX Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$434,433,000 (624.05%)

$60,000,000 (125.73%)

$26,581,000 (-2.84%)

$27,357,000 (-4.44%)

Cost of Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Selling General & Administrative Expense

$43,462,000 (29.77%)

$33,491,000 (5.52%)

$31,739,000 (16.70%)

$27,196,000 (45.92%)

Research & Development Expense

$138,128,000 (14.95%)

$120,161,000 (-4.80%)

$126,215,000 (0.17%)

$126,006,000 (69.12%)

Operating Expenses

$181,590,000 (18.18%)

$153,652,000 (-2.72%)

$157,954,000 (3.10%)

$153,202,000 (64.48%)

Interest Expense

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Income Tax Expense

$4,220,000 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

$275,188,000 (448.54%)

-$78,955,000 (38.02%)

-$127,393,000 (-1.47%)

-$125,551,000 (-89.80%)

Net Income to Non-Controlling Interests

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income

$275,188,000 (448.54%)

-$78,955,000 (38.02%)

-$127,393,000 (-1.47%)

-$125,551,000 (-89.80%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income Common Stock

$275,188,000 (448.54%)

-$78,955,000 (38.02%)

-$127,393,000 (-1.47%)

-$125,551,000 (-89.80%)

Weighted Average Shares

$61,566,989 (8.46%)

$56,763,559 (15.74%)

$49,042,232 (5.87%)

$46,322,910 (34.67%)

Weighted Average Shares Diluted

$65,077,722 (14.65%)

$56,763,559 (15.74%)

$49,042,232 (5.87%)

$46,322,910 (34.67%)

Earning Before Interest & Taxes (EBIT)

$279,408,000 (453.88%)

-$78,955,000 (38.02%)

-$127,393,000 (-1.47%)

-$125,551,000 (-95.42%)

Gross Profit

$434,433,000 (624.05%)

$60,000,000 (125.73%)

$26,581,000 (-2.84%)

$27,357,000 (-4.44%)

Operating Income

$252,843,000 (369.98%)

-$93,652,000 (28.71%)

-$131,373,000 (-4.39%)

-$125,845,000 (-95.06%)

PTGX Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

-$299,483,000 (-662.86%)

-$39,258,000 (-142.92%)

$91,468,000 (676.72%)

-$15,860,000 (82.56%)

Net Cash Flow from Financing

$25,853,000 (-84.83%)

$170,477,000 (804.96%)

$18,838,000 (-85.50%)

$129,923,000 (-47.53%)

Net Cash Flow from Operations

$184,152,000 (362.19%)

-$70,236,000 (35.05%)

-$108,137,000 (-0.25%)

-$107,865,000 (-48.81%)

Net Cash Flow / Change in Cash & Cash Equivalents

-$89,478,000 (-246.73%)

$60,983,000 (2833.29%)

$2,079,000 (-65.76%)

$6,072,000 (-92.80%)

Net Cash Flow - Business Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Cash Flow - Investment Acquisitions and Disposals

-$298,128,000 (-671.37%)

-$38,649,000 (-141.89%)

$92,263,000 (725.13%)

-$14,759,000 (83.69%)

Capital Expenditure

-$1,355,000 (-122.50%)

-$609,000 (23.40%)

-$795,000 (27.79%)

-$1,101,000 (-133.76%)

Issuance (Repayment) of Debt Securities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Issuance (Purchase) of Equity Shares

$0 (0%)

$132,659,000 (811.56%)

$14,553,000 (-88.25%)

$123,829,000 (-51.51%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

$0 (0%)

$0 (0%)

-$90,000 (28.57%)

-$126,000 (-172.00%)

Share Based Compensation

$37,554,000 (28.20%)

$29,293,000 (21.04%)

$24,202,000 (47.62%)

$16,395,000 (107.56%)

Depreciation Amortization & Accretion

$2,895,000 (-12.59%)

$3,312,000 (-1.69%)

$3,369,000 (21.41%)

$2,775,000 (1.91%)

PTGX Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

100.00% (0.00%)

100.00% (0.00%)

100.00% (0.00%)

100.00% (0.00%)

Profit Margin

63.30% (148.10%)

-131.60% (72.54%)

-479.30% (-4.45%)

-458.90% (-98.57%)

EBITDA Margin

65.00% (151.55%)

-126.10% (72.97%)

-466.60% (-3.97%)

-448.80% (-108.84%)

Return on Average Equity (ROAE)

47.70% (273.45%)

-27.50% (44.44%)

-49.50% (-22.83%)

-40.30% (-3.60%)

Return on Average Assets (ROAA)

42.50% (267.98%)

-25.30% (41.03%)

-42.90% (-21.53%)

-35.30% (-20.48%)

Return on Sales (ROS)

64.30% (148.86%)

-131.60% (72.54%)

-479.30% (-4.45%)

-458.90% (-104.50%)

Return on Invested Capital (ROIC)

65.90% (178.83%)

-83.60% (8.43%)

-91.30% (-39.18%)

-65.60% (3.24%)

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0% (0%)

Price to Earnings Ratio (P/E)

8.63 (152.35%)

-16.5 (-293.14%)

-4.2 (66.75%)

-12.62 (-20.19%)

Price to Sales Ratio (P/S)

5.47 (-74.78%)

21.69 (7.77%)

20.13 (-65.24%)

57.91 (139.08%)

Price to Book Ratio (P/B)

3.41 (-13.26%)

3.93 (57.81%)

2.49 (-54.25%)

5.44 (97.28%)

Debt to Equity Ratio (D/E)

0.1 (63.49%)

0.06 (-58.00%)

0.15 (-5.66%)

0.16 (-0.63%)

Earnings Per Share (EPS)

4.47 (421.58%)

-1.39 (46.54%)

-2.6 (4.06%)

-2.71 (-41.15%)

Sales Per Share (SPS)

7.06 (567.55%)

1.06 (95.02%)

0.54 (-8.29%)

0.59 (-28.97%)

Free Cash Flow Per Share (FCFPS)

2.97 (337.90%)

-1.25 (43.81%)

-2.22 (5.57%)

-2.35 (-10.89%)

Book Value Per Share (BVPS)

10.97 (84.93%)

5.93 (34.92%)

4.4 (-32.13%)

6.48 (-20.32%)

Tangible Assets Book Value Per Share (TABVPS)

12.1 (91.82%)

6.31 (24.75%)

5.05 (-32.65%)

7.51 (-20.43%)

Enterprise Value Over EBIT (EV/EBIT)

8 (157.14%)

-14 (-366.67%)

-3 (75.00%)

-12 (-9.09%)

Enterprise Value Over EBITDA (EV/EBITDA)

7.72 (153.41%)

-14.46 (-361.98%)

-3.13 (74.68%)

-12.36 (-9.62%)

Asset Turnover

0.67 (248.96%)

0.19 (115.73%)

0.09 (15.58%)

0.08 (-39.37%)

Current Ratio

12.48 (-25.32%)

16.71 (114.39%)

7.8 (0.71%)

7.74 (-1.30%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

$182,797,000 (358.02%)

-$70,845,000 (34.96%)

-$108,932,000 (0.03%)

-$108,966,000 (-49.36%)

Enterprise Value (EV)

$2,180,262,495 (99.32%)

$1,093,835,337 (181.79%)

$388,175,664 (-74.43%)

$1,518,028,363 (118.76%)

Earnings Before Tax (EBT)

$279,408,000 (453.88%)

-$78,955,000 (38.02%)

-$127,393,000 (-1.47%)

-$125,551,000 (-93.62%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

$282,303,000 (473.20%)

-$75,643,000 (39.01%)

-$124,024,000 (-1.02%)

-$122,776,000 (-99.56%)

Invested Capital

$610,944,000 (304.35%)

$151,091,000 (59.61%)

$94,661,000 (-49.07%)

$185,872,000 (7.55%)

Working Capital

$544,243,000 (62.80%)

$334,303,000 (57.77%)

$211,898,000 (-28.59%)

$296,720,000 (7.76%)

Tangible Asset Value

$744,725,000 (108.05%)

$357,951,000 (44.38%)

$247,928,000 (-28.69%)

$347,695,000 (7.16%)

Market Capitalization

$2,300,483,495 (73.94%)

$1,322,559,337 (146.40%)

$536,754,664 (-67.12%)

$1,632,305,363 (111.64%)

Average Equity

$577,244,500 (100.94%)

$287,265,250 (11.67%)

$257,245,000 (-17.45%)

$311,615,500 (83.48%)

Average Assets

$648,121,750 (107.68%)

$312,072,750 (4.99%)

$297,227,500 (-16.46%)

$355,793,500 (57.84%)

Invested Capital Average

$423,910,250 (349.00%)

$94,413,000 (-32.34%)

$139,546,750 (-27.12%)

$191,472,500 (101.94%)

Shares

59,598,018 (3.33%)

57,678,122 (17.24%)

49,198,411 (3.08%)

47,728,227 (24.76%)